Sartorius Stedim Biotech
ISIN: FR0013154002 | Ticker: DIM | LEI: 52990006IVXY7GCSSR39
Country: France
Sartorius Stedim Biotech is a leading partner of the biopharma industry. Our solutions are supporting our customers to produce drugs safely, timely and economically. The key product categories of our company are cell cultivation, fermentation, filtration, purification, and fluid management.
Sartorius Stedim Biotech has a worldwide presence, with manufacturing, sales and R&D sites in more than 20 countries in Europe, North America and Asia. More than 10,400 employees across the globe focus on single-use technologies and added-value services to meet the rapidly changing technology requirements of the industry it serves.
1870
Served areaWorldwide
Headcount10,400
HeadquartersZone Industrielle les Paluds Avenue de Jouques, 13781 Aubagne Cedex – France
| Line item in (eur) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Assets | N/A | 2,856,733,000.00 | 3,951,100,000.00 | 5,065,400,000.00 |
| Noncurrent Assets | N/A | 1,982,789,000.00 | 2,495,500,000.00 | 3,394,200,000.00 |
| Property Plant And Equipment | N/A | 644,272,000.00 | 928,400,000.00 | 1,292,000,000.00 |
| Goodwill | N/A | 725,148,000.00 | 820,700,000.00 | 1,136,400,000.00 |
| Intangible Assets Other Than Goodwill | N/A | 571,882,000.00 | 684,400,000.00 | 876,800,000.00 |
| Deferred Tax Assets | N/A | 27,481,000.00 | 46,500,000.00 | 61,600,000.00 |
| Other Noncurrent Nonfinancial Assets | N/A | 509,000.00 | 700,000.00 | 2,500,000.00 |
| Current Assets | N/A | 873,945,000.00 | 1,455,600,000.00 | 1,671,200,000.00 |
| Inventories | N/A | 471,034,000.00 | 783,000,000.00 | 1,024,800,000.00 |
| Current Tax Assets Current | N/A | 6,055,000.00 | 14,700,000.00 | 14,000,000.00 |
| Other Current Financial Assets | N/A | 20,983,000.00 | 15,000,000.00 | 31,400,000.00 |
| Other Current Nonfinancial Assets | N/A | 59,217,000.00 | 63,300,000.00 | 89,400,000.00 |
| Cash and cash equivalents | 28,166,000.00 | 59,800,000.00 | 223,600,000.00 | 107,100,000.00 |
| Equity And Liabilities | N/A | 2,856,733,000.00 | 3,951,100,000.00 | 5,065,400,000.00 |
| Equity | 1,188,883,000.00 | 1,461,000,000.00 | 1,733,200,000.00 | 2,514,200,000.00 |
| Issued Capital | N/A | 18,436,000.00 | 18,400,000.00 | 18,400,000.00 |
| Capital Reserve | N/A | 231,526,000.00 | 231,500,000.00 | 231,500,000.00 |
| Equity Attributable To Owners Of Parent | N/A | 1,438,124,000.00 | 1,655,900,000.00 | 2,449,300,000.00 |
| Noncontrolling Interests | N/A | 22,876,000.00 | 77,400,000.00 | 64,900,000.00 |
| Noncurrent Liabilities | N/A | 827,893,000.00 | 1,180,800,000.00 | 1,515,300,000.00 |
| Noncurrent Provisions For Employee Benefits | N/A | 47,393,000.00 | 43,700,000.00 | 31,700,000.00 |
| Other Longterm Provisions | N/A | 6,488,000.00 | 7,700,000.00 | 12,300,000.00 |
| Deferred Tax Liabilities | N/A | 85,076,000.00 | 125,800,000.00 | 178,300,000.00 |
| Other Noncurrent Financial Liabilities | N/A | 125,816,000.00 | 418,500,000.00 | 181,200,000.00 |
| Longterm Borrowings | N/A | 515,657,000.00 | 521,100,000.00 | 1,020,600,000.00 |
| Current Liabilities | N/A | 567,840,000.00 | 1,037,100,000.00 | 1,035,900,000.00 |
| Current Provisions For Employee Benefits | N/A | 59,899,000.00 | 97,200,000.00 | 74,100,000.00 |
| Other Shortterm Provisions | N/A | 20,746,000.00 | 30,900,000.00 | 25,700,000.00 |
| Current Tax Liabilities Current | N/A | 71,524,000.00 | 165,000,000.00 | 209,600,000.00 |
| Other Current Financial Liabilities | N/A | 29,241,000.00 | 147,300,000.00 | 119,700,000.00 |
| Other Current Nonfinancial Liabilities | N/A | 55,472,000.00 | 85,100,000.00 | 97,100,000.00 |
| Current Borrowings And Current Portion Of Noncurrent Borrowings | N/A | 13,112,000.00 | 25,500,000.00 | 4,500,000.00 |
| Line item in (eur) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|---|
| Revenue From Contracts With Customers | 1,910,081,000.00 | 2,887,000,000.00 | 3,492,700,000.00 |
| Other Income | N/A | 47,400,000.00 | 72,100,000.00 |
| Profit Loss From Operating Activities | 471,714,000.00 | 865,400,000.00 | 995,200,000.00 |
| Finance Income | 27,014,000.00 | 22,300,000.00 | 185,800,000.00 |
| Finance Costs | 38,034,000.00 | 241,000,000.00 | 50,700,000.00 |
| Profit Loss Before Tax | 460,694,000.00 | 646,700,000.00 | 1,130,400,000.00 |
| Income Tax Expense Continuing Operations | 122,095,000.00 | 232,400,000.00 | 250,500,000.00 |
| Profit (loss) | 338,598,000.00 | 414,300,000.00 | 879,900,000.00 |
| Profit Loss Attributable To Owners Of Parent | 335,932,000.00 | 414,400,000.00 | 876,100,000.00 |
| Profit Loss Attributable To Noncontrolling Interests | 2,666,000.00 | -100,000.00 | 3,800,000.00 |
| Line item in (eur) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Profit (loss) | N/A | 338,598,000.00 | 414,300,000.00 | 879,900,000.00 |
| Adjustments For Decrease Increase In Inventories | N/A | -116,617,000.00 | -275,400,000.00 | -217,900,000.00 |
| Adjustments For Provisions | N/A | 3,447,000.00 | 6,700,000.00 | 400,000.00 |
| Other Adjustments For Noncash Items | N/A | 926,000.00 | 1,400,000.00 | 2,300,000.00 |
| Adjustments For Losses Gains On Disposal Of Noncurrent Assets | N/A | 127,000.00 | 0.00 | N/A |
| Interest Received Classified As Operating Activities | N/A | N/A | 5,900,000.00 | 5,600,000.00 |
| Income Taxes Paid Refund Classified As Operating Activities | N/A | 113,980,000.00 | 166,600,000.00 | 221,200,000.00 |
| Cash Flows From Used In Operating Activities | N/A | 416,878,000.00 | 701,900,000.00 | 612,300,000.00 |
| Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | N/A | 470,617,000.00 | 141,700,000.00 | 515,600,000.00 |
| Other Inflows Outflows Of Cash Classified As Investing Activities | N/A | 8,694,000.00 | 400,000.00 | -11,400,000.00 |
| Cash Flows From Used In Investing Activities | N/A | -621,116,000.00 | -465,200,000.00 | -957,500,000.00 |
| Proceeds From Borrowings Classified As Financing Activities | N/A | 334,788,000.00 | 74,200,000.00 | 566,800,000.00 |
| Interest Paid Classified As Financing Activities | N/A | 8,064,000.00 | 8,300,000.00 | 10,300,000.00 |
| Cash Flows From Used In Financing Activities | N/A | 234,066,000.00 | -77,700,000.00 | 220,700,000.00 |
| Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | N/A | 29,829,000.00 | 159,000,000.00 | -124,500,000.00 |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | N/A | 1,767,000.00 | 4,800,000.00 | 8,000,000.00 |
| Cash and cash equivalents | 28,166,000.00 | 59,800,000.00 | 223,600,000.00 | 107,100,000.00 |
Please note that some sums might not add up.
FR0013154002
LEI52990006IVXY7GCSSR39
SectorHealth Care Equipment & Services
IndustryHealth Care Equipment & Supplies
Sub-IndustryCAC Next 20
Main Stock ExchangeKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.